INSTITUTO DE SALUD CARLOS III
Monforte De Lemos 5 – Madrid – 28029
VAT: ESQ2827015E
http://www.isciii.es
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, INSTITUTO DE SALUD CARLOS III has received € 8,877,441.0 for its participation in a total of 25 project(s) with a total cost of € 595,532,645.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-01 | 643390 | HNN 2.0 | 2019-11-30 | coordinator | € 566,312.49 | € 2,082,673 | 2 | 16 | CORDIS ↪ | |
| 2015-11-01 | 681055 | JPI-EC-AMR | bacteriology · antibiotic resistance | 2021-12-31 | participant | € 224,812.0 | € 23,812,500 | 1 | 19 | CORDIS ↪ |
| 2016-12-01 | 727565 | HDHL-INTIMIC | public health · nutrition · microbiology | 2023-05-31 | participant | € 224,812.5 | € 10,602,500 | 1 | 19 | CORDIS ↪ |
| 2016-11-01 | 723770 | EuroNanoMed III | 2022-10-31 | coordinator | € 212,850.0 | € 15,270,000 | 1 | 29 | CORDIS ↪ | |
| 2021-01-01 | 963864 | JPIAMR-ACTION | antibiotics · antibiotic resistance | 2025-12-31 | participant | € 224,812.5 | € 26,311,250 | 1 | 26 | CORDIS ↪ |
| 2015-10-01 | 680969 | ERA-CVD | cardiovascular diseases · employment | 2022-12-31 | participant | € 245,437.5 | € 19,103,750 | 1 | 23 | CORDIS ↪ |
| 2018-12-01 | 825207 | FLAG-ERA III | 2024-11-30 | participant | € 59,812.5 | € 20,241,134 | 1 | 24 | CORDIS ↪ | |
| 2017-12-01 | 779282 | ERA PerMed | 2023-11-30 | coordinator | € 184,812.5 | € 32,195,000 | 1 | 33 | CORDIS ↪ | |
| 2016-01-01 | 688945 | EuBI PPII | medical and health sciences | 2018-12-31 | participant | € 1,500.0 | € 1,497,910 | 1 | 21 | CORDIS ↪ |
| 2020-01-01 | 869178 | AquaticPollutants | bacteriology · ecosystems · limnology · antibiotic resistance | 2024-12-31 | participant | € 0.0 | € 18,181,814 | 1 | 34 | CORDIS ↪ |
| 2019-01-01 | 825664 | JPCOFUND2 | neurology | 2024-12-31 | participant | € 265,036.53 | € 33,438,899 | 1 | 32 | CORDIS ↪ |
| 2015-01-01 | 643271 | ERACoSysMed | 2020-06-30 | participant | € 224,812.0 | € 14,778,271 | 1 | 15 | CORDIS ↪ | |
| 2017-01-01 | 733296 | EXEDRA | 2021-12-31 | participant | € 63,125.0 | € 2,231,438 | 1 | 16 | CORDIS ↪ | |
| 2021-01-28 | 101037867 | VACCELERATE | pandemics · coronaviruses · vaccines | 2024-01-27 | participant | € 502,128.55 | € 26,499,804 | 1 | 32 | CORDIS ↪ |
| 2015-01-01 | 643638 | TRANSCAN-2 | 2021-06-30 | participant | € 215,743.0 | € 22,568,750 | 1 | 34 | CORDIS ↪ | |
| 2014-12-01 | 643578 | E-Rare-3 | pharmaceutical drugs | 2020-11-30 | participant | € 221,827.0 | € 23,290,000 | 1 | 26 | CORDIS ↪ |
| 2016-12-01 | 733274 | TO-REACH | 2021-05-31 | participant | € 1,106.11 | € 2,041,496 | 1 | 29 | CORDIS ↪ | |
| 2021-03-01 | 964264 | TRANSCAN-3 | 2026-02-28 | participant | € 306,081.27 | € 34,081,623 | 1 | 32 | CORDIS ↪ | |
| 2021-01-01 | 964215 | NEURON Cofund2 | neurobiology · psychiatry · social inequalities | 2025-12-31 | participant | € 172,388.0 | € 28,291,026 | 1 | 26 | CORDIS ↪ |
| 2016-01-01 | 680966 | NEURON Cofund | neurobiology | 2022-12-31 | participant | € 257,812.5 | € 20,882,250 | 1 | 23 | CORDIS ↪ |
| 2015-01-01 | 643417 | JPco-fuND | neurobiology · databases | 2021-09-30 | participant | € 157,799.43 | € 30,953,030 | 1 | 27 | CORDIS ↪ |
| 2020-02-01 | 871075 | ELIXIR-CONVERGE | ecosystems | 2023-07-31 | participant | € 0.01 | € 9,821,915 | 1 | 57 | CORDIS ↪ |
| 2017-01-01 | 733032 | HBM4EU | 2022-06-30 | participant | € 3,379,745.21 | € 74,930,474 | 1 | 121 | CORDIS ↪ | |
| 2019-01-01 | 825173 | EULAC-PerMed | public health · personalized medicine · health care services | 2022-12-31 | coordinator | € 397,099.81 | € 2,065,618 | 1 | 13 | CORDIS ↪ |
| 2019-01-01 | 825575 | EJP RD | ecosystems | 2023-12-31 | participant | € 767,581.85 | € 100,359,517 | 2 | 157 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, INSTITUTO DE SALUD CARLOS III has received € 20,883,217.0 for its participation in a total of 8 project(s) with a total cost of € 1,306,972,533.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 101130574 | ALADDIN | immunisation · oncology · mammalogy · mathematical model | 2027-12-31 | participant | € 374,745.0 | € 3,315,441 | 1 | 8 | CORDIS ↪ |
| 2022-11-01 | 101095426 | ERA4Health | public health · nanomedicine · nutrition · cardiovascular diseases | 2029-10-31 | coordinator | € 1,795,796.43 | € 110,150,222 | 1 | 45 | CORDIS ↪ |
| 2023-04-01 | 101104587 | ECHoS | 2026-03-31 | associatedPartner | € nan | € 6,185,678 | 1 | 55 | CORDIS ↪ | |
| 2023-11-01 | 101137129 | EP PerMed | 2033-10-31 | participant | € 8,563,171.88 | € 335,251,551 | 1 | 54 | CORDIS ↪ | |
| 2023-01-01 | 101095654 | THCS | 2029-12-31 | participant | € 2,178,900.0 | € 305,248,586 | 1 | 64 | CORDIS ↪ | |
| 2024-09-01 | 101156595 | ERDERA | ecosystems | 2031-08-31 | participant | € 1,899,967.27 | € 145,830,619 | 2 | 178 | CORDIS ↪ |
| 2022-05-01 | 101057036 | DESIGN OH AMR | public health · virology · mycology · nutrition · antibiotic resistance | 2024-09-30 | participant | € 6,250.0 | € 990,433 | 1 | 13 | CORDIS ↪ |
| 2022-05-01 | 101057014 | PARC | public health · crisis management | 2029-04-30 | participant | € 6,064,388.15 | € 400,000,000 | 1 | 199 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, INSTITUTO DE SALUD CARLOS III has received € 2,269,934.0 for its participation in a total of 11 project(s) with a total cost of € 24,717,157.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-01-01 | 321529 | INFECT-ERA | 2016-12-31 | participant | € 194,633.0 | € 2,281,955 | 1 | 19 | CORDIS ↪ | |
| 2010-10-01 | 260748 | FIT FOR HEALTH | 2013-09-30 | participant | € 41,818.0 | € 2,277,919 | 1 | 29 | CORDIS ↪ | |
| 2012-01-01 | 291840 | ERA-NET NEURON II | 2015-12-31 | participant | € 96,995.5 | € 2,206,402 | 1 | 23 | CORDIS ↪ | |
| 2008-05-01 | 201068 | HEALTH-NCP-NET | 2013-04-30 | coordinator | € 836,965.9 | € 2,242,207 | 1 | 22 | CORDIS ↪ | |
| 2009-01-01 | 234811 | EURONANOMED | 2011-12-31 | participant | € 114,569.0 | € 1,529,032 | 1 | 24 | CORDIS ↪ | |
| 2012-11-01 | 321570 | EURONANOMED II | 2016-10-31 | participant | € 87,290.0 | € 1,765,720 | 1 | 23 | CORDIS ↪ | |
| 2012-09-01 | 323209 | JPIAMR | antibiotic resistance | 2016-02-29 | participant | € 81,320.0 | € 2,497,205 | 1 | 11 | CORDIS ↪ |
| 2013-09-01 | 602139 | PERMED | 2015-08-31 | participant | € 40,125.0 | € 645,115 | 1 | 18 | CORDIS ↪ | |
| 2011-01-01 | 266559 | TRANSCAN | 2014-12-31 | participant | € 138,386.0 | € 2,415,483 | 1 | 29 | CORDIS ↪ | |
| 2010-10-01 | 266608 | E-RARE-2 | 2014-11-30 | participant | € 192,658.0 | € 2,920,521 | 1 | 18 | CORDIS ↪ | |
| 2011-03-01 | 261391 | EUROWESTNILE | RNA viruses · virology · epidemiology · ecology · molecular biology | 2014-08-31 | coordinator | € 445,175.2 | € 3,935,592 | 1 | 16 | CORDIS ↪ |